Expertise in
6
conditions

Dr. Rachel E. Raab

Hematology Oncology | Hematology | Oncology
American Oncology Partners PA
551 Brevard Rd, 
Asheville, NC 
Accepting New Patients
Offers Telehealth
Expertise in
6
conditions
American Oncology Partners PA
551 Brevard Rd, 
Asheville, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rachel Raab is a Hematologist Oncology specialist and a Hematologist in Asheville, North Carolina. Dr. Raab is highly rated in 6 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, Endometrial Cancer, and Bone Marrow Aspiration. Dr. Raab is currently accepting new patients.

Her clinical research consists of co-authoring 9 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in NC
Hospital Affiliations
Adventhealth Hendersonville
Memorial Mission Hospital And Asheville Surgery Ce
The Mcdowell Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

AMERICAN ONCOLOGY PARTNERS PA
551 Brevard Rd, Asheville, NC 28806

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 2 Study of Atezolizumab With or Without Entinostat in Patients With Advanced Triple Negative Breast Cancer, With a Phase 1b Lead in Phase
A Randomized, Placebo-controlled, Double-blind, Multicenter Phase 2 Study of Atezolizumab With or Without Entinostat in Patients With Advanced Triple Negative Breast Cancer, With a Phase 1b Lead in Phase
Enrollment Status: Completed
Publish Date: December 04, 2024
Intervention Type: Drug
Study Drugs: Entinostat, Atezolizumab
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

9 Total Publications

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A.
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A.
Journal: JCO oncology practice
Published: June 21, 2022
Similar Doctors
Expertise in
56
conditions
Dr. Michael J. Messino
Hematology Oncology | Hematology | Oncology
Expertise in
56
conditions
Dr. Michael J. Messino
Hematology Oncology | Hematology | Oncology
551 Brevard Rd, 
Asheville, NC 
 (0.1 miles away)
828-212-7021
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Messino is a Hematologist Oncology specialist and a Hematologist in Asheville, North Carolina. Dr. Messino is highly rated in 56 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Embryonal Tumor with Multilayered Rosettes, Ependymoma, Gliosarcoma, and Bone Marrow Aspiration. Dr. Messino is currently accepting new patients.

Expertise in
43
conditions
Dr. Trevor C. Austin
Hematology Oncology | Hematology | Oncology
Expertise in
43
conditions
Dr. Trevor C. Austin
Hematology Oncology | Hematology | Oncology

American Oncology Partners PA

551 Brevard Rd, 
Asheville, NC 
 (0.1 miles away)
828-212-7021
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Trevor Austin is a Hematologist Oncology specialist and a Hematologist in Asheville, North Carolina. Dr. Austin is highly rated in 43 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Chronic Lymphocytic Leukemia (CLL), Bone Marrow Aspiration, and Gastrostomy. Dr. Austin is currently accepting new patients.

Expertise in
54
conditions
Dr. Martin Palmeri
Hematology Oncology | Hematology | Oncology
Expertise in
54
conditions
Dr. Martin Palmeri
Hematology Oncology | Hematology | Oncology

American Oncology Partners PA

551 Brevard Rd, 
Asheville, NC 
 (0.1 miles away)
828-212-7021
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Martin Palmeri is a Hematologist Oncology specialist and a Hematologist in Asheville, North Carolina. Dr. Palmeri is highly rated in 54 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, Bone Marrow Aspiration, and Gastrostomy. Dr. Palmeri is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Raab's expertise for a condition
ConditionClose
    View All 70 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile